USPTO trademark

STEMCELL TECHNOLOGIES

Under examinationUSPTOWord markClass 1Class 5Class 9Class 42+1

"STEMCELL TECHNOLOGIES" is a word mark owned by STEMCELL Technologies Canada Inc., filed at the USPTO on December 18, 2019. It is under examination and covers classes 1, 5, 9, 42 and 44.

Official USPTO record
STEMCELL TECHNOLOGIES trademark as filed
As filed with the USPTO
Status
Under examination
Since May 28, 2026
Filed
December 18, 2019
Registered
Not yet
Priority date
July 12, 2019
Claimed from Canada
Application no.
88732568
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
5 classes
Ownership

Who owns STEMCELL TECHNOLOGIES

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services STEMCELL TECHNOLOGIES is filed for, grouped by Nice class.

  • Growth media, tissue culture media, cryopreservation media, cytokines, small molecules for research applications, cells, antibodies, and reagents; cell separation reagents; tissue culture media, growth factors, small molecules, growth media, serum, nutritional supplements and cryopreservation media for the in vitro culturing, development, maintenance, expansion, assay or manipulation of cells; kits comprising molecular tags and reagents for labelling antibodies; coatings of biological materials and cryopreservation media for the growth, expansion, differentiation or manipulation of cells, microorganisms, tissues, or organs; reagents and kits comprised of reagents; specialized liquid and semi-liquid media and support reagents and cryopreservation media for growth, cloning or experimental analysis of cells; all for scientific, research, laboratory, and non-medical diagnostic use

  • Growth media, tissue culture media, cryopreservation media, cytokines, small molecules for research applications, cells, antibodies, and reagents; cell separation reagents; tissue culture media, growth factors, small molecules, growth media, serum, nutritional supplements and cryopreservation media for the in vitro culturing, development, maintenance, expansion, assay or manipulation of cells; kits comprising molecular tags and reagents for labelling antibodies; coatings of biological materials and cryopreservation media for the growth, expansion, differentiation or manipulation of cells, microorganisms, tissues, or organs; reagents and kits comprised of reagents; specialized liquid and semi-liquid media and support reagents and cryopreservation media for growth, cloning or experimental analysis of cells; all for medical and medical clinical use

  • Scientific instrument comprising hardware and recorded software for the automated separation and analysis of biological and non-biological materials; laboratory equipment, namely, cell separation equipment; downloadable computer software used for the collection, organization, analysis, integration and communication of scientific data; laboratory equipment, namely, laboratory glassware, culture dishes, wells, in the nature of plastic trays with depressions, pipettors, pumps, needles and syringes for laboratory use; bioreactors, namely, fermentation reactors for laboratory use

  • Consultation, research and development services in the field of hematology, immunology, therapeutic research, and life science; scientific research services, namely, contract assays services and proficiency testing services in the field of hematology, immunology, therapeutic research, and life science; providing information on the subject of scientific research in the field of biochemistry and biotechnology; providing on-line non-downloadable computer software used for the collection, organization, analysis, integration and communication of scientific data

  • Medical services, namely, medical diagnostic services, disease therapy services and transplant services

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notification of letter of suspension e-mailed
  2. Letter of suspension e-mailed
  3. Suspension letter written
  4. Teas/email correspondence entered
  5. Correspondence received in law office
  6. Teas response to suspension inquiry received
  7. Notification of inquiry as to suspension e-mailed
  8. Inquiry to suspension e-mailed
  9. Suspension inquiry written
  10. Suspension checked - to attorney for action

10 earlier steps on the official record.

FAQ

About STEMCELL TECHNOLOGIES

Who owns the trademark "STEMCELL TECHNOLOGIES"?

The USPTO trademark "STEMCELL TECHNOLOGIES" (application 88732568) is owned by STEMCELL Technologies Canada Inc.

What is the status of "STEMCELL TECHNOLOGIES"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull STEMCELL TECHNOLOGIES and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2b3d-8f9e-75a0-84ae-9e53a809abc5
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b3d-8f9e-75a0-84ae-9e53a809abc5",
  "object": "trademark",
  "mark_text": "STEMCELL TECHNOLOGIES",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "88732568",
  "filing_date": "2019-12-18",
  "nice_classes": [
    1,
    5,
    9,
    42,
    44
  ],
  "owners": [
    {
      "name": "STEMCELL Technologies Canada Inc.",
      "entity_id": "ent_019eb6fe-23e1-77d0-a406-ff48992a79c1"
    }
  ]
}